603168.SS · 莎普爱思
China A-shares · RS rating 65 · As of 2026-10-14
| Price | 5.79 CNY |
|---|---|
| 1-day change | -1.7% |
| RS rating (overall / 1M / 3M / 12M) | 65 / 60 / 90 / 29 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 18 / 12 / 15 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -0.6% |
| Distance from 52-week high | +31.7% |
| Market cap (USD) | $331.5M |